| Prevention of venous thromboembolism in 2020 and beyond M Nicholson, N Chan, V Bhagirath, J Ginsberg Journal of clinical medicine 9 (8), 2467, 2020 | 148 | 2020 |
| Comparison of the proinflammatory and procoagulant properties of nuclear, mitochondrial, and bacterial DNA VC Bhagirath, DJ Dwivedi, PC Liaw Shock 44 (3), 265-271, 2015 | 120 | 2015 |
| Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism NC Chan, V Bhagirath, JW Eikelboom Vascular Health and Risk Management, 343-351, 2015 | 99 | 2015 |
| Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: a retrospective study S Piran, H Traquair, N Chan, V Bhagirath, S Schulman Research and practice in thrombosis and haemostasis 2 (4), 684-688, 2018 | 74 | 2018 |
| Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism C Kearon, S Parpia, FA Spencer, T Baglin, SM Stevens, KA Bauer, ... Blood, The Journal of the American Society of Hematology 131 (19), 2151-2160, 2018 | 71 | 2018 |
| Apixaban-calibrated anti-FXa activity in relation to outcome events and clinical characteristics in patients with atrial fibrillation: results from the AVERROES trial VC Bhagirath, JW Eikelboom, J Hirsh, M Coppens, J Ginsberg, ... TH Open 1 (02), e139-e145, 2017 | 34 | 2017 |
| Apixaban for stroke prevention in atrial fibrillation: why are event rates higher in clinical practice than in randomized trials?—a systematic review TAC de Vries, J Hirsh, K Xu, I Mallick, VC Bhagirath, JW Eikelboom, ... Thrombosis and haemostasis 120 (09), 1323-1329, 2020 | 27 | 2020 |
| Reduction in mortality following elective major hip and knee surgery: a systematic review and meta-analysis K Xu, NC Chan, Q Ibrahim, P Kruger, S Sinha, V Bhagirath, J Ginsberg, ... Thrombosis and Haemostasis 119 (04), 668-674, 2019 | 27 | 2019 |
| Current challenges in diagnosis of venous thromboembolism Z Liederman, N Chan, V Bhagirath Journal of Clinical Medicine 9 (11), 3509, 2020 | 21 | 2020 |
| Rivaroxaban and aspirin in peripheral vascular disease: a review of implementation strategies and management of common clinical scenarios GR McClure, E Kaplovitch, S Narula, VC Bhagirath, SS Anand Current Cardiology Reports 21, 1-9, 2019 | 21 | 2019 |
| Quantification of cell-free DNA in red blood cell units in different whole blood processing methods AW Shih, VC Bhagirath, NM Heddle, JP Acker, Y Liu, JW Eikelboom, ... Journal of blood transfusion 2016, 2016 | 21 | 2016 |
| Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk … LA Minuk, K Monkman, IH Chin-Yee, A Lazo-Langner, V Bhagirath, ... Leukemia & lymphoma 53 (1), 57-63, 2012 | 19 | 2012 |
| Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura VC Bhagirath, JG Kelton, J Moore, DM Arnold Transfusion 52 (12), 2517-2523, 2012 | 18 | 2012 |
| The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series TM Chan, D Jo, AW Shih, VC Bhagirath, LA Castellucci, C Yeh, B Thoma, ... Perspectives on Medical Education 7, 219-223, 2018 | 15 | 2018 |
| Low-dose rivaroxaban plus aspirin for the prevention of cardiovascular events: an evaluation of COMPASS VC Bhagirath, JW Eikelboom, SS Anand Future Cardiology 14 (6), 443-453, 2018 | 14 | 2018 |
| Management of bleeding complications in the anticoagulated patient VC Bhagirath, L O'Malley, MA Crowther Seminars in hematology 48 (4), 285-294, 2011 | 14 | 2011 |
| Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism? SK Medeiros, B Emery, V Bhagirath, S Parpia, DJ Dwivedi, NJ Dwivedi, ... Thrombosis Research 186, 13-19, 2020 | 13 | 2020 |
| A national canadian survey of antithrombotic therapy after urgent and emergent limb revascularization GR McClure, E Kaplovitch, N Chan, V Bhagirath, J Harlock, D Szalay, ... Canadian Journal of Cardiology 37 (3), 504-507, 2021 | 12 | 2021 |
| Building your peripheral artery disease toolkit: medical management of peripheral artery disease in 2022 VC Bhagirath, D Nash, D Wan, SS Anand Canadian Journal of Cardiology 38 (5), 634-644, 2022 | 11 | 2022 |
| Feasibility of a web-based platform (trial my app) to efficiently conduct randomized controlled trials of mHealth apps for patients with cardiovascular risk factors: protocol … C Lokker, R Jezrawi, I Gabizon, J Varughese, M Brown, D Trottier, ... JMIR research protocols 10 (2), e26155, 2021 | 9 | 2021 |
